[Study on the expression of p62 protein in patients with lung adenocarcinoma].

Zeng, B J; Ji, P; Sun, Z J; Wu, J L; Shang, A Q; Quan, W W; Li, D

Zeng, B J; Ji, P; Sun, Z J; Wu, J L; Shang, A Q; Quan, W W; Li, D.

Afiliação

Zeng BJ; Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Ji P; Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Sun ZJ; Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Wu JL; Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Shang AQ; Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Quan WW; Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Li D; Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.

Zhonghua Yu Fang Yi Xue Za Zhi ; 55(5): 685-690, 2021 May 06.

Article em Zh | MEDLINE | ID: mdl-34034412

Assuntos

Adenocarcinoma de Pulmão; Adenocarcinoma; Neoplasias Pulmonares; Biomarcadores Tumorais; China; Estudos Transversais; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google